These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18535200)

  • 1. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders.
    Higgins JM; Sloan SR
    Blood; 2008 Sep; 112(6):2546-53. PubMed ID: 18535200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell alloimmunization from an African perspective.
    Natukunda B; Brand A; Schonewille H
    Curr Opin Hematol; 2010 Nov; 17(6):565-70. PubMed ID: 20827185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-related red blood cell alloantibodies: induction and consequences.
    Tormey CA; Hendrickson JE
    Blood; 2019 Apr; 133(17):1821-1830. PubMed ID: 30808636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell alloantibodies are associated with increased alloimmunization against human leukocyte antigens.
    Belizaire R; Mack J; Kadauke S; Kim Y; Saidman S; Makar RS
    Transfusion; 2019 Jul; 59(7):2256-2263. PubMed ID: 30980544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is female sex a risk factor for red blood cell alloimmunization after transfusion? A systematic review.
    Verduin EP; Brand A; Schonewille H
    Transfus Med Rev; 2012 Oct; 26(4):342-53, 353.e1-5. PubMed ID: 22244869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.
    Fasano RM; Booth GS; Miles M; Du L; Koyama T; Meier ER; Luban NL
    Br J Haematol; 2015 Jan; 168(2):291-300. PubMed ID: 25256676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.
    Nickel RS; Hendrickson JE; Fasano RM; Meyer EK; Winkler AM; Yee MM; Lane PA; Jones YA; Pashankar FD; New T; Josephson CD; Stowell SR
    Transfusion; 2016 Jan; 56(1):107-14. PubMed ID: 26509333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloimmunization to red blood cell antigens by transfusion.
    Mintz PD
    Blood; 2010 May; 115(21):4315; author reply 4315-6. PubMed ID: 20508173
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of alloimmunization in sickle cell disease.
    Hudson KE; Fasano RM; Karafin MS; Hendrickson JE; Francis RO
    Curr Opin Hematol; 2019 Nov; 26(6):434-441. PubMed ID: 31483335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red Cell Alloantibodies in Thalassaemia Patients Who Received Ten or More Units of Transfusion.
    Sarkar SK; Shah MS; Begum M; Yunus AM; Aziz MA; Kabir AL; Khan MR; Rahman F; Rahman A
    Mymensingh Med J; 2019 Apr; 28(2):364-369. PubMed ID: 31086152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B; Schonewille H; van de Watering L; Brand A
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Back to base pairs: What is the genetic risk for red bloodcell alloimmunization?
    Gerritsma JJ; Oomen I; Meinderts S; van der Schoot CE; Biemond BJ; van der Bom JG; Fijnvandraat K;
    Blood Rev; 2021 Jul; 48():100794. PubMed ID: 33451870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irradiation of Red Blood Cells and Alloimmunization.
    Tormey CA; Hendrickson JE
    Lab Med; 2017 May; 48(2):172-177. PubMed ID: 28340248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressants and alloimmunization against red blood cell transfusions.
    Zalpuri S; Evers D; Zwaginga JJ; Schonewille H; de Vooght KM; le Cessie S; van der Bom JG
    Transfusion; 2014 Aug; 54(8):1981-7. PubMed ID: 24689865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.
    Karafin MS; Westlake M; Hauser RG; Tormey CA; Norris PJ; Roubinian NH; Wu Y; Triulzi DJ; Kleinman S; Hendrickson JE;
    Br J Haematol; 2018 Jun; 181(5):672-681. PubMed ID: 29675950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red Blood Cell Alloimmunization in Multitransfused Pediatric Population in a Tertiary Care Hospital.
    Poornima AP; Fazal S; Shaiji PS; Usha KC; Kailas L
    Indian J Pediatr; 2019 Mar; 86(3):245-249. PubMed ID: 30515703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte-reactive antibodies are associated with red blood cell alloimmunization.
    Schönbacher M; Heinzl MW; Dauber EM; Mayr WR; Panzer S; Körmöczi GF
    Vox Sang; 2014 Aug; 107(2):200-3. PubMed ID: 24712334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.
    Sins JW; Biemond BJ; van den Bersselaar SM; Heijboer H; Rijneveld AW; Cnossen MH; Kerkhoffs JL; van Meurs AH; von Ronnen FB; Zalpuri S; de Rijke YB; Ellen van der Schoot C; de Haas M; van der Bom JG; Fijnvandraat K
    Am J Hematol; 2016 Aug; 91(8):763-9. PubMed ID: 27102719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.